Ozempic and Mounjaro: Understanding the Difference

Both medicines belong to the GLP-1 class — they work on appetite-regulating pathways in the body, commonly leading to reduced hunger and a greater sense of fullness after eating. Slower gastric emptying is also frequently reported. However, there are meaningful differences worth understanding.

Active substance and mechanism

• Ozempic contains semaglutide, a GLP-1 receptor agonist. In the context of weight management specifically, semaglutide at a higher dose is marketed as Wegovy — so Ozempic and Wegovy share the same active substance at different licensed doses. You can read more about how Ozempic and Wegovy relate to each other.
• Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. Activating both receptors is what distinguishes it mechanically from semaglutide-based medicines.

How they are taken

Both are supplied as pre-filled injection pens and administered once a week. Both are typically started at a lower dose, with the prescriber adjusting over time — the exact schedule is individual and always directed by the prescriber, never self-managed.

Are they interchangeable?

No. These are different medicines with different active substances. Switching between them, or deciding which to take, is a clinical decision that belongs entirely with a prescriber or doctor. Neither medicine is universally "better" — suitability depends on individual health factors that only a qualified professional can assess. For a more detailed factual comparison, see our Mounjaro vs Ozempic informational comparison.

A note on naming

People sometimes use "Ozempic" loosely to refer to any GLP-1 weight-loss injection. Technically, Ozempic is a specific brand (semaglutide, originally licensed for type 2 diabetes management), distinct from Mounjaro (tirzepatide). If you are unsure which medicine you have been prescribed, your dispensing label and patient information leaflet will confirm it — or ask your prescriber or pharmacist.

For broader context on Mounjaro specifically, the Mounjaro overview covers what it is, how it works, and what to expect on your journey.

GLP Trackr is built for people already prescribed Mounjaro or a semaglutide-based medicine — and it works the same way whichever you have been given. The most immediately useful feature for anyone navigating a weekly injection schedule is dose and injection logging: every shot is recorded with its date, dose strength, and injection site, so you always have a clear record of where you are in your treatment.

Beyond that, the app's side-effect tracker lets you log how you feel after each dose — nausea, fatigue, changes in appetite — and builds a pattern over time. That kind of organised record is genuinely useful to bring to a prescriber appointment, particularly when you're adjusting to a new medicine or a new dose stage. GLP Trackr also includes weight and progress tracking, so you can watch your journey unfold week by week rather than relying on a single weigh-in.

Whatever you have been prescribed, the app does not replace the guidance of your prescriber or doctor — it helps you stay consistent and informed so your conversations with them are as useful as possible. If you have any questions about your medicine, side effects, or whether it is working as expected, your healthcare professional is always the right person to ask.

Ready to bring everything together in one place? GLP Trackr is free to try for 7 days — available on the App Store and Google Play. Log your first dose today and start building a record that actually means something.